CIK 0001061983 · Large accelerated filer
CYTOKINETICS INC
Sign in to watch- Ticker
- CYTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 943291317
- Phone
- (650) 624-3000
- Business address
- 350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
- 4 Planned sale Director sold 5,000 shares at $64.73 ($323,650)
- 144 Insider Sale of Securities
- 4 Planned sale EVP Research & Development sold 2,200 shares at $66.45 ($146,190)
- 4 Grant or award Chief Legal & Admin Officer acquired 87,297 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale Director sold 5,175 shares at $65.08 ($336,789)
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 4 Gift President & CEO gave 2,000 shares (gift)
- 8-K Event Results of operations
- 4 Planned sale EVP Research & Development sold 2,295 shares at $59.55 ($136,667)
- 4 Planned sale President & CEO sold 5,000 shares at $62.86 ($314,300)
- 4 Planned sale Director sold 4,375 shares at $58.68 ($256,725)
- 144 Insider Sale of Securities
- 4 Planned sale EVP Research & Development sold 2,105 shares at $58.22 ($122,553)
- 144 Insider Sale of Securities
- 4 Grant or award Director acquired 99 shares (grant or award)
Page 10 of 127 · 2,534 filings